484 Results (Page 11 of 20)
UAE Markets Research Reports
UAE Electronic Records Management Solutions Market Analysis
UAE's electronic records management solutions market size was valued at $xx Mn in 2022 and is estimated to expand at a compound annual growth rate (CAGR) of xx% from 2022-30 and will reach $xx Mn in 2030. The market is segmented by solution and deployment. The UAE electronic records management solutions market is growing as the UAE government has put in place several programs to encourage the adoption of electronic records management technologies, including the UAE Vision 2021 and the Dubai Paperless Strategy. The key market players are Cerner Middle East and Africa, Epic Systems Corporation, Allscripts Healthcare Solutions, Inc., InterSystems Corporation, GE Healthcare, and others.
UAE ENT Devices Market Analysis
UAE ENT Devices Market is projected to grow from $120 Mn in 2022 to $200 Mn by 2030, registering a CAGR of 6.8% during the forecast period of 2022-30. The rising prevalence of ENT disorders, such as hearing loss, sinusitis, and tonsillitis, is a major driver of the ENT device market. The market is highly competitive, with a large number of players operating in the space, ranging from small, specialized companies to large multinational corporations. The domestic key players in the UAE ENT devices market include Atico Medical, Noor Al Khaldiah, and Al Sahel Medical Equipment.
UAE Diabetes Therapeutics Market Analysis
UAE's diabetes therapeutics market is expected to grow from $719 Mn in 2022 to $1,622 Mn in 2030 with a CAGR of 10.7% for the forecasted year 2022-30. The development of novel and ground-breaking treatment options along with supportive government programs like Thiqa and Saada are driving the growth of the market. The UAE diabetes therapeutics market is segmented by type, application, drug, route of administration, and distribution channel. Rimo Pharmaceuticals, Medspero Pharma, and Boehringer Ingelheim are the major players in the UAE diabetes therapeutics market.
UAE Age-Related Macular Degeneration Therapeutics Market Analysis
The UAE Age-Related Macular Degeneration (AMD) Therapeutics Market was valued at US $54 Mn in 2022 and is predicted to grow at a CAGR of 9.9% from 2023 to 2030, to US $115 Mn by 2030. The key drivers of this industry include the rising trend in the prevalence of age-related macular degeneration, the rapidly growing economy of the country, and other factors. The industry is primarily dominated by players such as Regeneron Pharmaceuticals, Novartis, Roche, Bayer, and Genetech, among others.
UAE Depression Therapeutics Market Analysis
UAE depression therapeutics market is expected to grow from $51 Mn in 2022 to $82 Mn in 2030 with a CAGR of 6.2% for the forecasted year 2022-30. The growing awareness of depression and the supportive government initiatives to minimize the stigma associated with mental health disorders in the UAE are the major market drivers. The UAE depression therapeutics market is segmented by drug type, therapies, indication, and end users. Sahara Pharmaceutical, Viatris, and Allergan are the major players in the UAE depression therapeutics market.
UAE Coronary Stents Market Analysis
UAE's Coronary Stents Market is expected to witness growth from $57 Mn in 2022 to $88 Mn in 2030 with a CAGR of 5.75% for the forecasted year 2022-30. In the UAE, the prevalence of coronary artery disease is increasing as a result of factors such as poor diet, smoking, and rising obesity rates. As a result, the need for coronary stents to treat the condition is rising. The market is segmented by type and by gender. Some key players in this market include Neopharma, Emirates Biotech Pharmaceutical, Medtronic, GE Healthcare, Boston Scientific, and Philips Healthcare.
UAE Contraceptive Devices Market Analysis
UAE's Contraceptive Devices Market is expected to witness growth from $65 Mn in 2022 to $129 Mn in 2030 with a CAGR of 6.00% for the forecasted year 2022-30. In the UAE, particularly among young people, there is a high frequency of STDs. Because of this, there is an increased need for barrier methods of contraception like condoms, which is boosting the market for contraceptive manufacturers. The market is segmented by type and by gender. Some key players in this market include Julphar Life, Neopharma, Mylan Laboratories, Mankind Pharma, CooperSurgical, Pfizer, and Teva Pharmaceutical.
UAE Clinical Trials Support Service Market Analysis
This report presents a strategic analysis of the UAE Clinical Trials Support Service Market and a forecast for its development in the medium and long term. It provides a broad overview of the market dynamics, trends and insights, growth drivers and restraints, segmentation, competitive landscape, healthcare policies and regulatory framework, reimbursement scenario, challenges, and future outlook. This is one of the most comprehensive reports about the UAE Clinical Trials Support Service Market, offering unmatched value, accuracy, and expert insights.
UAE Cardiovascular Diseases Therapeutics Market Analysis
UAE's cardiovascular disease therapeutics market is projected to grow from $813 Mn in 2022 to $1,530 Mn in 2030 with a CAGR of 8.22% for the year 2022-30. The rise in sedentary lifestyles adopted by the UAE citizens and the technological advancement of cardiovascular therapeutics in the UAE are responsible for the growth of the market. The UAE cardiovascular disease therapeutics market is segmented by disease indication, drug type, route of administration, drug classification, mode of purchase, and end user. Lumitive, Hikma Pharmaceuticals, and F. Hoffmann-La Roche are the major players in the UAE cardiovascular disease therapeutics market.
UAE Cancer Immunotherapy Market Analysis
UAE's cancer immunotherapy market is expected to witness growth from $563 Mn in 2022 to $1,049 Mn in 2030 with a CAGR of 8.1% for the forecasted year 2022-30. The increasing incidence of cancer in the UAE along with favorable government initiatives to promote the use of immunotherapy treatment in the UAE are responsible for the growth of the market. The UAE cancer immunotherapy market is segmented by type, application, and end user. Lamba, Neopharma, and Bayer are the major players in the UAE cancer immunotherapy market.
UAE Artificial Intelligence (AI) in Diagnostics Market Analysis
UAE Artificial Intelligence (AI) In the diagnostics market is projected to grow from $0.01 Bn in 2022 to $0.06 Bn by 2030, registering a CAGR of 36% during the forecast period of 2022-30. The market will be driven by technical improvements, increased healthcare spending, and an increasing preference for more precise and individualized diagnostic technology. The market is segmented by component & by diagnosis. Some of the major players include GE Healthcare, IBM Watson Health & Prognica Labs.
UAE Acne Drugs Market Analysis
This report presents a strategic analysis of the UAE Acne Drugs Market and a forecast for its development in the medium and long term. It provides a broad overview of the market dynamics, trends and insights, growth drivers and restraints, segmentation, competitive landscape, healthcare policies and regulatory framework, reimbursement scenario, challenges, and future outlook. This is one of the most comprehensive reports about the UAE Acne Drugs Market, offering unmatched value, accuracy, and expert insights.
UAE Addiction Therapeutics Market Analysis
UAE addiction therapeutics market was valued at $51 Mn in 2022 and is estimated to reach $93 Mn in 2030, exhibiting a CAGR of 7.9% during the forecast period. The rise in mental health awareness and awareness about addiction treatments through government encouragement and support has increased investments in addiction therapeutics infrastructure which has in turn reduced the social stigma associated with it. These changes in environment have led to an increase in the addiction treatment drug market in the UAE. Some major key players in UAE addiction therapeutics are Viatris, Sahara Pharmaceutical, AbbVie, Pfizer, Indivior, Reckitt Benckiser Pharmaceuticals, Mundipharma, Teva Pharmaceutical, Alkermes and Hikma
UAE Adult Malignant Glioma Therapeutics Market Analysis
The UAE Adult Glioma Therapeutics Market is valued at around $11 Mn in 2022 and is projected to reach $23 Mn by 2030, exhibiting a CAGR of 9.9% during the forecast period. The UAE Market is fuelled due to drivers like increasing partnerships with globally established firms and research institutions, an increased aging population and acceptance and investments in technological advancements by the government to decrease healthcare problems. Key players in the UAE Adult Malignant Glioma Therapeutics Market include companies like Arbor Pharmaceuticals, Amneal Pharmaceuticals, Karyopharm, Roche, Bio-Rad Laboratories, Azurity Pharmaceuticals and Merck & Co. among others.
UAE Actinic Keratosis Therapeutic Market Analysis
The UAE Actinic Keratosis Therapeutics Market, currently valued at $34 Mn in 2022, is predicted to increase to $54 Mn by 2030 and the forecasted CAGR between 2022 and 2030 is projected to be 5.9%. The key drivers of such growth are assumed to be the sun-drenched demographics, amplified public understanding of the condition and its treatment options, and a burgeoning arsenal of therapies, including cutting-edge technology and minimally invasive procedures. Key players in the UAE Keratosis Therapeutics Market include Bayer, Galderma, LEO Pharma Inc., Sun Pharmaceutical Industries Ltd., Julphar, Pharmax Pharma, Pharmalink, among others
UAE Over The Counter (OTC) Pharmaceuticals Market Analysis
UAE over-the-counter (OTC) pharmaceuticals market size was valued at $687.5 Mn in 2022 and is estimated to expand at a CAGR of 6.54% from 2022 to 2030 and will reach $1141.2 Mn in 2030. OTC are non-prescription medications and are a vital component of the healthcare system, offering consumers accessible solutions for a wide range of common health issues. The market is segmented by product type and distribution channel. The key market players are Johnson and Johnson Services Inc (USA), Bayer AG (Germany), Novartis AG (Switzerland) and others.
UAE Women's Health Market Analysis
UAE Women’s Health Market is projected to grow from $200 Mn in 2022 to $314 Mn by 2030, registering a CAGR of 5.80% during the forecast period of 2022-30. The UAE women's health market is expected to grow in the coming years, driven by factors such as an aging population, increased awareness of women's / issues, and government initiatives to promote women's health. There are some of the major companies operating in the UAE women's health market include pharmaceutical giants such as Pfizer and Roche, AstraZeneca.
UAE Radiotherapy Market Analysis
By 2030, it is anticipated that the UAE Radiotherapy Market will reach a value of $59 Mn from $35 Mn in 2022, growing at a CAGR of 7% during 2022-2030. The Radiotherapy Therapeutics Market in UAE is dominated by a few domestic players such as Elekta, IBA Proton Therapy, and Elekta. The radiotherapy market in UAE is segmented into different types, technologies, procedures, applications, and end-users. The major risk factors associated with awareness of radiotherapy shortage of skilled staff, government initiatives, and reimbursement policy. The demand for UAE Radiotherapy is increasing on account of the rise in cancer cases in the country.
UAE Bioinformatics Market Analysis
UAE Bioinformatics market is projected to grow from $76.75 Mn in 2022 to $275.08 Mn by 2030, registering a CAGR of 1.30% during the forecast period of 2022-30. The main factors driving the growth are government initiatives, advances in technology, and an increasing demand for personalized medicine. The market is segmented by technology and by application. Some of the major players include G42 Healthcare (ARE), Neo-Science (ARE), Agilent Technologies, IBM Life Sciences, and QIAGEN.
UAE Acne Therapeutics Market Analysis
UAE's acne therapeutics market is projected to grow from $50 Mn in 2022 to $91 Mn in 2030 with a CAGR of 7.7% for the year 2022-30. as the citizens of UAE are becoming more aware of their skin and appearance. A plethora of therapeutic options available for the treatment of acne in the UAE is also responsible for the growth of the market. The UAE acne therapeutics market is segmented by treatment, route of administration, age group, and distribution channel. Pharmalink, UltraPharma, and Teva Pharmaceuticals are some of the key competitors in the market.
UAE ADHD (Attention Deficit Hyperactivity Disorder) Drugs Market Analysis
UAE ADHD (Attention Deficit Hyperactivity Disorder) Drugs Market is projected to grow from $148 Mn in 2022 to $222 Mn by 2030, registering a CAGR of 5.20% during the forecast period of 2022-30. The UAE government plays a significant role in the market through its reimbursement policies and regulations, which can affect the pricing and availability of drugs. Some of the major players in the UAE ADHD drugs market include Shire (now part of Takeda), Novartis, and Janssen.
UAE Healthcare Financial Analytics Market Analysis
The UAE Healthcare Financial Analytics market size was valued at $xx Mn in 2022 and is estimated to expand at a compound annual growth rate (CAGR) of 7.8% from 2022 to 2030 and will reach $xx Mn in 2030. The market is segmented by type, component, and deployment. UAE’s Healthcare Financial Analytics market will grow as rising healthcare costs, increasing demand for better patient outcomes, and the growing adoption of digital technologies in healthcare. The key market players are Healthbit, Pulsus Healthtech, Fórmula Médica, Kryptus, and others.
UAE Biosimilars Market Analysis
The UAE biosimilars market size was valued at $96 Mn in 2022 and is estimated to expand at a compound annual growth rate (CAGR) of 23.2% from 2022 to 2030 and will reach $510 Mn in 2030. The market is segmented by product type and indication type. The UAE Biosimilars market will grow as biosimilars are less expensive than their reference products, and patients can afford to use biosimilars as a therapy alternative. The key market players are Neopharma, Julphar, Pfizer, Roche, and others.
UAE Multiple Myeloma Therapeutics Market Analysis
UAE's multiple myeloma therapeutics market was valued at $42 Mn in 2022 and is estimated to expand at a CAGR of 5.5% from 2022 to 2030 and will reach $64 Mn in 2030. One of the main reasons propelling the growth of this Market is the growing demand for innovative therapies and the aging population. The market is segmented by type, drug, and distribution channel. Some key players in this market are Julphar, Neopharma, Medpharma, LifePharma, Gulf Pharmaceutical, Pharmax Pharmaceuticals, and others.
UAE Pharmaceutical Market Analysis
This report presents a strategic analysis of the UAE Pharmaceutical Market and a forecast for its development in the medium and long term. It provides a broad overview of the market dynamics, trends and insights, growth drivers and restraints, segmentation, competitive landscape, healthcare policies and regulatory framework, reimbursement scenario, challenges and future outlook. This is one of the most comprehensive reports about the UAE Pharmaceutical Market, offering unmatched value, accuracy and expert insights.